[Clinical importance of paraprotein of the type kappa and lambda in Bence-Jones myeloma].
D000328:Adult; D000368:Aged; D001536:Bence Jones Protein / Q000032:analysis*; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007147:Immunoglobulin Light Chains / Q000032:analysis*; D007145:Immunoglobulin kappa-Chains / Q000032:analysis*; D007146:Immunoglobulin lambda-Chains / Q000032:analysis*; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy / Q000378:metabolism*
D007147:Immunoglobulin Light Chains; D007145:Immunoglobulin kappa-Chains; D007146:Immunoglobulin lambda-Chains; D003520:Cyclophosphamide; D001536:Bence Jones Protein; D008558:Melphalan
Klinicheskoe znachenie paraproteina tipa kappa i lambda pri mielome Bens-Dzhonsa.